The System of Decision for Product Security
Cyber Insight helps regulated manufacturers turn vulnerability findings into traceable, product-specific security decisions — from the data they already have.
Scanners produce findings. Ticketing manages work. Cyber Insight produces product-specific decisions—with the evidence and uncertainty behind it.
DECISION FLOW
From Findings to Decisions
Findings
CVEs, SBOMs and vulnerability feeds create the starting point.
Context
Architecture, configuration and deployment explain the real product.
Evidence
Evidence-based reasoning is following your shipped product.
Decision
Decision is made on evidence if a vulnerability is causing risk or not.
A Finding is Not a Product Decision
Product security teams rarely fail because they lack feeds. They lose time separating meaningful product risk from noisy CVEs, false positives and component matches that still have to survive review.
A CVE in an SBOM is not enough
Reachability, exposure and product-specific controls decide whether the shipped product is actually affected.
Regulated devices need another path
Active testing can be risky, constrained or prohibited. The decision has to be made from incomplete, static evidence — by design, not as a shortcut.
Evidence must survive review
Regulated teams need decisions that are repeatable, reviewable and linked to evidence across the product lifecycle.
Decisions should not depend on individual experts
Relying on individual security experts throughout the entire product lifecycle is not scalable.
The Platform DARA
DARA turns incomplete product evidence into a reviewable decision path.
DARA is Cyber Insight’s neurosymbolic reasoning architecture—the foundation behind our products, ZYLENTIX and ThreatFinder. It assesses and determines whether a CVE poses a real risk in its specific context.
One Platform foundation.
Two commercial routes.
Shared reasoning, evidence handling and reviewable paths
The Platform layer stays the same. It is productized as ZYLENTIX for MedTech teams and embedded as ThreatFinder for partner platforms.
ZYLENTIX
Product-specific CVE decisions for regulated MedTech manufacturers
-
Assesses CVEs against the real device system
-
Keeps uncertainty visible and guides evidence completion
-
Produces reviewable VEX-ready decision output
ThreatFinder
Vulnerability matching and contextual prioritizations for partner platforms
-
Finds relevant vulnerable software version matches
-
Prioritzies CVEs using customer environment context
-
Embeds decisions support signals through OEM/API integration
Great teams. Great ideas.
Cyber Insight is building product-security decision infrastructure from Leipzig, Germany.
We combine deep cybersecurity expertise, AI engineering and enterprise go-to-market experience to help regulated manufacturers turn vulnerability findings into traceable, product-specific security decisions. DARA is the reasoning architecture behind Zylentix for MedTech and ThreatFinder for OEM/API partners.
Headquarters: Leipzig, Germany
Cyber Insight is headquartered in Leipzig, Germany, where our cybersecurity, AI engineering and enterprise teams build and deliver the DARA platform and its applications.